Adenocarcinoma, Clear Cell
|
0.010 |
Biomarker
|
disease |
BEFREE |
A recent large-scale screen of ∼3,500 genes by PCR-based exon re-sequencing identified several new cancer genes in ccRCC including UTX (also known as KDM6A), JARID1C (also known as KDM5C) and SETD2 (ref.2).
|
21248752 |
2011 |
Aggressive behavior
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Alopecia Areata
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Autism Spectrum Disorders
|
0.020 |
Biomarker
|
disease |
BEFREE |
Loss-of-function mutations in the histone demethylases KDM5A, KDM5B, or KDM5C are found in intellectual disability (ID) and autism spectrum disorders (ASD) patients.
|
30902578 |
2019 |
Autism Spectrum Disorders
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
A novel mutation in JARID1C/SMCX in a patient with autism spectrum disorder (ASD).
|
18203167 |
2008 |
Autistic Disorder
|
0.440 |
Biomarker
|
disease |
BEFREE |
Intriguingly, mutations within the genes encoding the H3K9-specific methyltransferase, EHMT1, and the H3K4-specific histone demethylase, JARID1C/SMCX, have been linked to mental retardation and autism, respectively.
|
18814864 |
2009 |
Autistic Disorder
|
0.440 |
Biomarker
|
disease |
CTD_human |
The JARID1C-regulated genes SCN2A, CACNA1H, BDNF, and SLC18A1 have previously been associated with autism and cognitive dysfunction.
|
18203167 |
2008 |
Autistic Disorder
|
0.440 |
Biomarker
|
disease |
BEFREE |
The JARID1C-regulated genes SCN2A, CACNA1H, BDNF, and SLC18A1 have previously been associated with autism and cognitive dysfunction.
|
18203167 |
2008 |
Autistic Disorder
|
0.440 |
Biomarker
|
disease |
HPO |
|
|
|
Autistic Disorder
|
0.440 |
Biomarker
|
disease |
BEFREE |
Altered Gene-Regulatory Function of KDM5C by a Novel Mutation Associated With Autism and Intellectual Disability.
|
29670509 |
2018 |
Autistic Disorder
|
0.440 |
AlteredExpression
|
disease |
BEFREE |
The KDM5C-3'UTR-lncRNA isoform was differentially expressed in autistic females with XCI skewness compared with controls.
|
31087518 |
2019 |
Babinski Reflex
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Brachydactyly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Breast Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Silencing JARID1C in breast cancer cells could inhibit cell migration and invasion.
|
26182878 |
2015 |
Byzanthine arch palate
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cafe au lait spots, multiple
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
We propose that RACK7/KDM5C functions as an enhancer "brake" to ensure appropriate enhancer activity, which, when compromised, could contribute to tumorigenesis.
|
27058665 |
2016 |
Cerebral Palsy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Ten de novo mutations in three previously identified disease genes (TUBA1A (n=2), SCN8A (n=1) and KDM5C (n=1)) and in six novel candidate CP genes (AGAP1, JHDM1D, MAST1, NAA35, RFX2 and WIPI2) were predicted to be potentially pathogenic for CP.
|
25666757 |
2015 |
Chromophobe Renal Cell Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
Class III malocclusion
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Clinodactyly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Clinodactyly of fingers
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Collecting Duct Carcinoma of the Kidney
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
Colon Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
KDM5c expression upregulation in colon cancer cells had significantly reduced L-OHP and CPT-11½ inhibitory concentrations (IC50 s) and decreased the ABCC1mRNA and protein expression.
|
30257334 |
2018 |
Congenital clubfoot
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|